Current enzyme replacement therapy for the treatment of lysosomal storage diseases.
Article Details
- CitationCopy to clipboard
Lim-Melia ER, Kronn DF
Current enzyme replacement therapy for the treatment of lysosomal storage diseases.
Pediatr Ann. 2009 Aug;38(8):448-55.
- PubMed ID
- 19725195 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Agalsidase alfa Globotriaosylceramide Group Humans UnknownMetabolizerLigandDetails Agalsidase beta Globotriaosylceramide Group Humans YesMetabolizerLigandDetails